Dyadic International Inc (DYAI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Dyadic International Inc (DYAI) has a cash flow conversion efficiency ratio of -0.710x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.85 Million) by net assets ($2.61 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See DYAI cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Dyadic International Inc - Cash Flow Conversion Efficiency Trend (2003–2024)
This chart illustrates how Dyadic International Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Dyadic International Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Dyadic International Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Rand Capital Corp
NASDAQ:RAND
|
0.009x |
|
TP ICAP Group PLC
LSE:TCAP
|
0.097x |
|
DS Sigma Holdings Berhad
KLSE:0269
|
0.005x |
|
INIFY LABORATORIES AB
F:WY60
|
N/A |
|
Qingdao Hengshun Zhongsheng
SHE:300208
|
-4.160x |
|
Shankara Building Products Limited
NSE:SHANKARA
|
-0.023x |
|
Petrolia SE
F:0PE
|
0.038x |
|
Archtis Ltd
AU:AR9
|
-0.252x |
Annual Cash Flow Conversion Efficiency for Dyadic International Inc (2003–2024)
The table below shows the annual cash flow conversion efficiency of Dyadic International Inc from 2003 to 2024. For the full company profile with market capitalisation and key ratios, see Dyadic International Inc stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $2.47 Million | $-3.97 Million | -1.609x | -40.62% |
| 2023-12-31 | $5.88 Million | $-6.73 Million | -1.144x | -56.95% |
| 2022-12-31 | $11.09 Million | $-8.08 Million | -0.729x | -18.90% |
| 2021-12-31 | $18.39 Million | $-11.28 Million | -0.613x | -165.32% |
| 2020-12-31 | $28.45 Million | $-6.57 Million | -0.231x | -43.33% |
| 2019-12-31 | $35.86 Million | $-5.78 Million | -0.161x | -55.31% |
| 2018-12-31 | $42.45 Million | $-4.41 Million | -0.104x | -99.07% |
| 2017-12-31 | $49.98 Million | $-2.61 Million | -0.052x | +50.15% |
| 2016-12-31 | $57.69 Million | $-6.04 Million | -0.105x | -861.81% |
| 2015-12-31 | $73.79 Million | $-802.67K | -0.011x | -100.40% |
| 2014-12-31 | $-2.26 Million | $-6.20 Million | 2.738x | +37.97% |
| 2013-12-31 | $2.57 Million | $5.10 Million | 1.984x | +871.06% |
| 2012-12-31 | $1.79 Million | $365.17K | 0.204x | -95.50% |
| 2011-12-31 | $-800.00K | $-3.63 Million | 4.538x | +244.91% |
| 2010-12-31 | $2.44 Million | $-7.64 Million | -3.131x | -432.71% |
| 2009-12-31 | $6.96 Million | $6.55 Million | 0.941x | +110.68% |
| 2008-12-31 | $1.46 Million | $-12.87 Million | -8.815x | -687.58% |
| 2007-12-31 | $13.50 Million | $-15.11 Million | -1.119x | -4091.22% |
| 2006-12-31 | $28.19 Million | $790.51K | 0.028x | +105.52% |
| 2005-12-31 | $15.38 Million | $-7.82 Million | -0.508x | -111.04% |
| 2004-12-31 | $24.57 Million | $-5.92 Million | -0.241x | -113.89% |
| 2003-12-31 | $-74.09K | $-128.49K | 1.734x | -- |
About Dyadic International Inc
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells industrial enzymes and other proteins in the United States and internationally. It utilizes the C1 platform in pharmaceutical applications, including the development and production of pharmaceutical products. The company offers Dapibus, a protein production platform that enable the rapid development and la… Read more